alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                              10
<SECURITIES>                                         0
<RECEIVABLES>                                    1,327
<ALLOWANCES>                                        76
<INVENTORY>                                      1,476
<CURRENT-ASSETS>                                 2,783
<PP&E>                                          59,377
<DEPRECIATION>                                  37,097
<TOTAL-ASSETS>                                  25,810
<CURRENT-LIABILITIES>                            1,996
<BONDS>                                              0
<PREFERRED-MANDATORY>                              210
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                      14,587
<TOTAL-LIABILITY-AND-EQUITY>                    25,810
<SALES>                                          2,998
<TOTAL-REVENUES>                                 9,443
<CGS>                                            1,410
<TOTAL-COSTS>                                    8,771
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                (927)
<INCOME-PRETAX>                                   (229)
<INCOME-TAX>                                        69
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (160)
<EPS-PRIMARY>                                     (.01)
<EPS-DILUTED>                                     (.01)


</TABLE>
#### State v. Kemfort.

18276

12/9/96

Affirmed
Breadcrumb

1. Home

2. Print 

3. Pdf 

4. Node 

5. Entity Print 

Aquatic Animals: Disease Sampling

and Testing Information

Last Modified: 

Print

Export disease testing of live aquatic animals may be required before shipping to

some countries. The Laboratory Export Testing Guidance clarifies definitions and

provides a decision tree outlining which laboratories must be used, in order to meet

the specific requirements of importing countries.

View Laboratory Export Testing Guidance

APHIS-Approved Laboratories

For quick reference, see the APHIS-Approved Laboratories lists below.

Approved Laboratories 

(PDF, 203.87 KB)

Find laboratories approved to conduct diagnostic testing in support of export health

certification of aquaculture species.

National Animal Health Laboratory Network 
The National Animal Health Laboratory Network (NAHLN) is a network of animal

disease diagnostic laboratories that provides ongoing disease surveillance, responds

quickly to disease events, communicates diagnostic outcomes to decision makers,

and has the capability and capacity to meet diagnostic needs during animal disease

outbreaks.

Export Disease Testing

The level of export disease testing of live aquatic animals may differ based on the

importing country. 

Some countries allow for pre-export testing of the population intended for

export within a specified timeframe prior to shipping, commonly referred to as

“test-and-ship.”

Check the country’s IRegs web page using the drop-down menu on the

APHIS International Regulations (IRegs) for Animal Exports page to see if

there are country-specific criteria for testing (e.g., testing within 60 days

of export for spring viremia of carp virus). 

If there are no negotiated requirements posted to the country’s IRegs web

page, then exporters must follow the APHIS Criteria for Test Negative

Status (111.43 KB).

Some countries require the facility/premises to be free from pathogens of

concern for a minimum of 2 consecutive years prior to shipping, commonly

referred to as “premises freedom.”

Check the country’s IRegs web page using the drop-down menu on the

APHIS International Regulations (IRegs) for Animal Exports page to see if

there are country-specific criteria for testing (e.g., testing within 60 days

of export for spring viremia of carp virus).

If there are no negotiated requirements posted to the country’s IRegs web

page, then exporters must follow the APHIS Criteria for Establishing

Premises Freedom (257.69 KB) which includes testing to meet 95%

confidence of detecting the pathogen at an assumed prevalence of 2%, as

well as biosecurity, for a minimum of 2 consecutive years.
152 P.3d 1236

SUPREME COURT OF HAWAI'I

#### Brooks v. Dana Nance & Co.

26736

01/31/2007

Denied

113 Hawai'i 406, 153 P.3d 1091
Breadcrumb

1. Hogar

2. Print 

3. Pdf 

4. Node 

5. Entity Print 

Funding Opportunities

Last Modified: 

Print

APHIS leads efforts to keep U.S. plants and animals healthy. Each year, we distribute

millions of dollars to producer organizations, State and Federal agencies, Native

American Tribes, universities, and others nationwide to support projects that help

strengthen our Nation's safeguarding system and prevent, control, or mitigate pests

or diseases. 

Application due May 20 2024

Antimicrobial Resistance Dashboard Funding Opportunity

Application due May 20 2024

Fondos: Up to $3 Million

Resumen: APHIS is offering a second round of competitive funding opportunities to

support the development and use of dashboards to address the One Health

challenge of antimicrobial resistance.

Detalles y elegibilidad

Ver mas Ver Menos

Get Ready To Apply!
Before you can apply for Federal funding, your organization must be registered with

the U.S. Government System for Award Management (SAM). Don't wait! It takes at

least 10 business days for new registrations to process. 

Learn more about the basics of our funding process and how you can get ready to

apply

Register with SAM today

Our Funding Programs

APHIS funding opportunities are available at various times throughout the year. Use

the links below to learn more about each opportunity.  

Chronic Wasting Disease Management and Response Funding Opportunities 

Funding is available for projects that help States, Tribes, universities, and others

control chronic wasting disease in wild and farmed cervids, such as deer and elk.

Plant Pest and Disease Management and Disaster Prevention Program 

Funding is available for projects that strengthen and safeguard our Nation’s

agricultural infrastructure by preventing, detecting, and mitigating invasive plant

pests and diseases.

National Animal Disease Preparedness and Response Program 

Funding is available for projects that help States, Tribes, producers, and others

prevent, prepare for, and respond to high-consequence animal disease outbreaks.

National Animal Health Laboratory Network Funding Opportunities 

Funding is available for projects that enhance the early detection of highconsequence animal diseases and improve emergency response capabilities in

veterinary diagnostic laboratories that are part of the network.

National Clean Plant Network 

Funding is available for projects that expand or create new clean plant centers

capable of producing and maintaining disease-free plant material for U.S. specialty

crop producers.
February 13, 2004

24752

#### Cedillos v. Gurgone

Affirmed
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 06-7517

VICTOR ROBERTS,

Petitioner - Appellant,

versus

GENE M. JOHNSON, Director of Virginia

Department of Corrections,

Respondent - Appellee.

Appeal from the United States District Court for the Eastern

District of Virginia, at Norfolk. Jerome B. Friedman, District

Judge. (2:05-cv-00331-JBF)

Submitted: February 23, 2007 Decided: March 20, 2007

Before WILLIAMS, TRAXLER, and DUNCAN, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Victor Roberts, Appellant Pro Se. Leah Ann Darron, Assistant

Attorney General, Steven Andrew Witmer, OFFICE OF THE ATTORNEY

GENERAL OF VIRGINIA, Richmond, Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.
- 2 -

PER CURIAM:

Victor Roberts, a state prisoner, seeks to appeal the

district court’s order accepting the recommendation of the

magistrate judge and denying relief on his 28 U.S.C. § 2254 (2000)

petition. The order is not appealable unless a circuit justice or

judge issues a certificate of appealability. 28 U.S.C.

§ 2253(c)(1) (2000). A certificate of appealability will not issue

absent “a substantial showing of the denial of a constitutional

right.” 28 U.S.C. § 2253(c)(2) (2000). A prisoner satisfies this

standard by demonstrating that reasonable jurists would find that

his constitutional claims are debatable and that any dispositive

procedural rulings by the district court are also debatable or

wrong. See Miller-El v. Cockrell, 537 U.S. 322, 336 (2003);

Slack v. McDaniel, 529 U.S. 473, 484 (2000); Rose v. Lee, 252 F.3d

676, 683 (4th Cir. 2001). We have independently reviewed the

record and conclude that Roberts has not made the requisite

showing. Accordingly, we deny a certificate of appealability and

dismiss the appeal. We dispense with oral argument because the

facts and legal contentions are adequately presented in the

materials before the court and argument would not aid the

decisional process. 

DISMISSED
170 P.3d 880

INTERMEDIATE COURT OF APPEALS OF HAWAI'I

November 15, 2007

27024

#### Ferreiro v. Davenport

Affirmed
<PAGE>

                                                                EXHIBIT 32(b)

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of DUSA Pharmaceuticals, Inc. (the
"Company") on Form 10-Q for the period ending March 31, 2004, as filed with the
Securities and Exchange Commission (the "Report"), I, Peter M. Chakoutis, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

            3)    The Report fully complies with the requirements of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

            4)    The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company.

 Date:   May 4, 2004                                  /s/ Peter M. Chakoutis
                                                       ---------------------
                                                      Peter M. Chakoutis

                                                      Vice President, Chief
                                                      Financial Officer
                                                      (principal financial
                                                      officer) and Controller
                                                      (principal accounting
                                                      officer)

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to the Company and will be retained
by the Company and furnished to the Securities and Exchange Commission or its
staff upon request.
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>                      <C> 
<PERIOD-TYPE>                   3-MOS                    6-MOS
<FISCAL-YEAR-END>                         MAY-31-1998              MAY-31-1998
<PERIOD-START>                            SEP-01-1997              JUN-01-1997
<PERIOD-END>                              NOV-30-1997              NOV-30-1997
<CASH>                                              0                   12,554
<SECURITIES>                                        0                        0
<RECEIVABLES>                                       0                   85,414
<ALLOWANCES>                                        0                    7,564
<INVENTORY>                                         0                   26,558
<CURRENT-ASSETS>                                    0                  137,823
<PP&E>                                              0                   24,581
<DEPRECIATION>                                      0                    9,964
<TOTAL-ASSETS>                                      0                  526,120
<CURRENT-LIABILITIES>                               0                   43,604
<BONDS>                                             0                  100,733
<PREFERRED-MANDATORY>                               0                        0
<PREFERRED>                                         0                        0
<COMMON>                                            0                      258
<OTHER-SE>                                          0                  365,490
<TOTAL-LIABILITY-AND-EQUITY>                        0                  526,120
<SALES>                                       123,257                  241,515
<TOTAL-REVENUES>                              123,257                  241,515
<CGS>                                          63,991                  125,343
<TOTAL-COSTS>                                 110,567                  219,700
<OTHER-EXPENSES>                                    0                        0
<LOSS-PROVISION>                                2,166                    4,504
<INTEREST-EXPENSE>                              1,774                    3,552
<INCOME-PRETAX>                                11,131                   18,781
<INCOME-TAX>                                    4,969                    8,665
<INCOME-CONTINUING>                            12,690                   21,815
<DISCONTINUED>                                      0                        0
<EXTRAORDINARY>                                     0                        0
<CHANGES>                                           0                        0
<NET-INCOME>                                    6,162                   10,116
<EPS-PRIMARY>                                    0.24                     0.40
<EPS-DILUTED>                                    0.24                     0.40
        


</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### National Science Foundation

# Federal Register CITATION OF PREVIOUS ANNOUNCEMENT:

 The meeting was noticed on November 28, 2023, at 88 FR 83164-65.

# PREVIOUSLY ANNOUNCED TIME AND DATE OF THE MEETING:

 Wednesday, November 29, 2023, from 10:00 a.m.-5:20 p.m. and Thursday, November 30, 2023, from 8:30 a.m.-2:05 p.m. Eastern.

# CHANGES IN THE MEETING:

 There are changes to two sessions on Wednesday, November 29, and one session on Thursday, November 30, 2023.

## November 29, 2023

### Original

#### Closed Session: 2:55-4:35 p.m.

    - NSF SAHPR Update
    - SAHPR-related Statement and Discussion with NSB
    - Vote to move into Executive Plenary Closed

#### Closed (Executive) Session: 4:35-5:20 p.m.

    - NSB/NSF Discussion of SAHPR-related Statement

## Updated

#### Closed Session: 2:55-4:50 p.m.

    - NSF SAHPR Update
    - SAHPR-related Statements and Discussion with NSB
    - Vote to move into Executive Plenary Closed

## Closed (Executive) Session: 4:50-5:30 p.m.

    - NSB/NSF Discussion of SAHPR-related Statements

## November 30, 2023

### Original

#### Open Session: 8:30-9:50 a.m.

    - NSB Chair's Opening Remarks
    - Presentation and Discussion, Office of the Chief Diversity and Inclusion Officer, Charles Barber
    - NSB Committee Reports

○ Committee on Awards and Facilities Next Generation Very Large Array

○ Committee on Oversight

○ NSB-NSF Commission on Merit Review

### Updated

#### Open Session: 9:15-9:50 a.m.

    - NSB Chair's Opening Remarks
    - NSB Committee Reports

○ Committee on Awards and Facilities Next Generation Very Large Array

○ Committee on Oversight

○ NSB-NSF Commission on Merit Review

# CONTACT PERSON FOR MORE INFORMATION: 

                        Point of contact for this meeting is: Chris Blair,                         *cblair@nsf.gov,*                         703/292-7000.                    

Ann E. Bushmiller,

Senior Legal Counsel to the National Science Board.

[FR Doc. 2023-26549 Filed 11-29-23; 4:15 pm]

BILLING CODE 7555-01-P
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFOMRATION EXTRACTED FROM THE
COMPANY'S FINANCIAL STATEMENTS CONTAINED IN THE COMPANY'S 10-Q FOR THE QUARTER
ENDED SEPTEMBER 30, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                      JUN-30-1997
<PERIOD-END>                           SEP-30-1996
<CASH>                                   1,989,234
<SECURITIES>                                     0
<RECEIVABLES>                            5,667,106
<ALLOWANCES>                              (396,428)
<INVENTORY>                                396,383
<CURRENT-ASSETS>                        10,369,903
<PP&E>                                   4,897,837
<DEPRECIATION>                            (741,191)
<TOTAL-ASSETS>                          16,553,200
<CURRENT-LIABILITIES>                    6,882,435
<BONDS>                                          0
<PREFERRED-MANDATORY>                            0
<PREFERRED>                                      0
<COMMON>                                 3,826,926
<OTHER-SE>                               2,553,646
<TOTAL-LIABILITY-AND-EQUITY>            16,553,200
<SALES>                                  8,552,087
<TOTAL-REVENUES>                         8,552,087
<CGS>                                    7,063,757
<TOTAL-COSTS>                            8,325,935
<OTHER-EXPENSES>                                 0
<LOSS-PROVISION>                                 0
<INTEREST-EXPENSE>                          76,276
<INCOME-PRETAX>                            226,412
<INCOME-TAX>                               101,919
<INCOME-CONTINUING>                        124,493
<DISCONTINUED>                                   0
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                               124,493
<EPS-PRIMARY>                                  .04
<EPS-DILUTED>                                  .04
        

</TABLE>
EXHIBIT 32.a



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Boston Capital Tax Credit Fund III L.P. (the "Fund") on Form 10-Q for the period ended June 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, John P. Manning, Principal Executive Officer of the general partner of the general partner of the Fund's general partner, C&M Management Inc., certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge, after due inquiry:



|(1) | The Report fully complies with the requirements of section 13(a)-15 or 15(d)-15 of the Securities and Exchange Act of 1934; and                  
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                  
|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Fund.



|Date:           |  |                            
|--------------- |  | ---------------------------
|August 14, 2009 |  | /s/ John P. Manning        
|                |  |                            
|                |  | John P. Manning            
|                |  | Principal Executive Officer



A signed original of this written statement required by Section 906, or other

document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Fund and will be retained by the Fund and furnished to the Securities and Exchange Commission or its staff upon request.
11/09/2010 11:56 2022675075 OFFICE OF RULEMAKING PAGE 22 

DEPARTMENTOF 

CKHOPEMONS 

:m r-ov -R P !• n 

James Chandler 

18 White Oak Drive 

West Grove, PA 19390-9176 

October 25,2010 

AdministratoT J. Randolph Babbitt 

Room 1010 

Re: Support these changes to the FAA's Flight Time/Duty Time NPRM 

Dear Adroniistrator Babbitt: 

As a US cominercial pilot revjewijig the FAA Notice of Proposed Rulemaking (NPRM) on Flight crew member 

Duty and Rest Requirements I am pleased that the majority of the NPRM represents an improvement to current 

regulations and covers all commercial operations ia the spirit of "One Level of Safety." However, there are some 

specific items ^at need to be changed in order to mitigate Bitigue for the professional pilot. 

1) The flight time limit should not be increased 25% from & hours to Id hours. 

2) The augmented (3 person) fligjit time limit should not be increased 25% from 12 to 15 hours. 

3) Rest requirements should be 10 hours domestic and 14 hours international. 9 hours, reducible to 8 hours is not 

ernough time to achieve restorative sleep, eat, and attend to personal hygiene between duty periods. 

4) Domestic augmentation should not be allowed. 

As a professional commercial aviator woridng at high speed in congested airspace, and dirough arduous weather 

conditions, I can tell you that fatigue mitigaticHi is paramount to improving the safety of the travelling public. The 

NTSB has held fetigue on its "Most Wanted List" for thirty years because it is a problem tibiat flight crews deal with 

on a daily basis. This FAA NPRM will go a long way to reducing fiitigue and increasing safety if these items arc 

addressed. 

James Chandler 

610 869-5944